Watch Taffy & Norman’s Stories With Librela

Over 21 Million+ Doses and Counting1

Librela has helped dogs all over the world get back to their playful, lovable selves.

Vet Testimonials

Librela empowers vets with an effective new tool to help relieve OA pain in dogs.

IMPORTANT SAFETY INFORMATION: For use in dogs only. Women who are pregnant, trying to conceive or breastfeeding should take extreme care to avoid self-injection. Hypersensitivity reactions, including anaphylaxis, could potentially occur with self-injection. Librela should not be used in breeding, pregnant or lactating dogs. Librela should not be administered to dogs with known hypersensitivity to bedinvetmab. The most common adverse events reported in a clinical study were urinary tract infections, bacterial skin infections and dermatitis. See full Prescribing Information.

INDICATIONS: For the control of pain associated with osteoarthritis in dogs.

References:

  1. Global pharmacovigilance data on file accessed through SAP/DataMart. Sept 2024.
ZPC-02734R4